Author Archives: oligofastx

Metaverse opens new opportunities for research and collaboration

If there is one word that distinguishes OLIGOFASTX and its philosophy, it is innovation. Thanks to our research efforts, we are able to advance our objective, which is none other than to improve the quality of life of patients affected by rare diseases that have no treatment. And this desire for innovation leads us to […]

World Cancer Day

As it could not be otherwise, from Oligofastx we join in the celebration of the World Cancer Day, February 4, promoted by The World Cancer Society World Health Organization the International Agency for Research on Cancer (IARC) and the International Union Against Cancer (UICC) with the aim of raising awareness and mobilizing society to advance […]

Cancer cachexia

Cancer cachexia is a complex metabolic syndrome characterized by marked loss of body weight, anorexia, asthenia, sarcopenia, and anemia. It is the most common manifestation of advanced malignant cancer, leading to death. Approximately half of all cancer patients experience cachexia and the prevalence is over 80% in terminally ill patients, with cachexia being responsible for […]

Providing solutions for rare diseases: a priority for the UN

Perhaps the definition is not the most accurate, but in reality a rare disease does nothing more than denominate a pathology that has not yet been studied, analyzed and against which there is, for the time being, no solution. The complexity of the processes to reach social development solutions for the improvement of patients’ quality […]